Cees van Herwaarden

1.7k citations

22 papers · 1.2k indexed · 1 hit paper · h-index 15

Pulmonary and Respiratory Medicine top 2%
Physiology top 5%
Epidemiology
Emergency Medical Services top 2%
Issues, ethics and legal aspects top 1%

Co-authors: Job van der Palen Gerhard Zielhuis Paul van der Valk Evelyn M. Monninkhof Marc Decramer Maureen Rutten‐van Mölken Dario Olivieri Wilfried De Backer
Topics: Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers)Respiratory Support and Mechanisms (10 papers)Asthma and respiratory diseases (9 papers)
Cited by: Issues, ethics and legal aspects Pulmonary and Respiratory Medicine Physiology
Journals: The Lancet American Journal of Respiratory and Critical Care Medicine Clinical Infectious Diseases
Partner nations: Netherlands Belgium Italy

In The Last Decade

Cees van Herwaarden

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

2005 473 citations Marc Decramer, Maureen Rutten‐van Mölken et al. The Lancet profile →

Peers

Countries citing papers authored by Cees van Herwaarden

Since Specialization

Citations

This map shows the geographic impact of Cees van Herwaarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cees van Herwaarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cees van Herwaarden more than expected).

Fields of papers citing papers by Cees van Herwaarden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cees van Herwaarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cees van Herwaarden. The network helps show where Cees van Herwaarden may publish in the future.

Co-authorship network of co-authors of Cees van Herwaarden

This figure shows the co-authorship network connecting the top 25 collaborators of Cees van Herwaarden. A scholar is included among the top collaborators of Cees van Herwaarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cees van Herwaarden. Cees van Herwaarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialbreakdown → 2005 ·The Lancet ·Marc Decramer,Maureen Rutten‐van Mölken,(unknown),Thierry Troosters,Cees van Herwaarden,Riccardo Pellegrino,(unknown),Dario Olivieri,Mario Del Donno,Wilfried De Backer,(unknown),Alfredo Ardia	473
2	Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial 2005 ·Marc Decramer,Maureen Rutten‐van Mölken,P.N.R. Dekhuijzen,T. Troosters,Cees van Herwaarden,Raffaele Pellegrino,(unknown),Dario Olivieri,Mario Del Donno,Wilfried De Backer,(unknown)	76
3	Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD 2004 ·CHEST Journal ·(unknown),Tjard Schermer,G. van den Boom,Reinier Akkermans,(unknown),Cees van Herwaarden,Chris van Weel	19
4	Clinical Predictors of Bacterial Involvement in Exacerbations of Chronic Obstructive Pulmonary Disease 2004 ·Clinical Infectious Diseases ·(unknown),Evelyn M. Monninkhof,Job van der Palen,Gerhard Zielhuis,Cees van Herwaarden,Ron Hendrix	35
5	Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease 2004 ·Chronic Respiratory Disease ·(unknown),Paul van der Valk,Tjard Schermer,Job van der Palen,Cees van Herwaarden,Gerhard Zielhuis	41
6	Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study 2003 ·Respiratory Medicine ·Pierre van Grunsven,Tjard Schermer,Reinier Akkermans,(unknown),G. van den Boom,Onno C. P. van Schayck,Cees van Herwaarden,Chris van Weel	27
7	The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre–post-test study 2003 ·Patient Education and Counseling ·Evelyn M. Monninkhof,Paul van der Valk,Job van der Palen,(unknown),Marcel E. Pieterse,Cees van Herwaarden,Gerhard Zielhuis	28
8	Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease 2003 ·European Respiratory Journal ·Evelyn M. Monninkhof,Paul van der Valk,Job van der Palen,Cees van Herwaarden,Gerhard Zielhuis	139
9	Management of stable COPD 2003 ·Patient Education and Counseling ·Paul van der Valk,Evelyn M. Monninkhof,Job van der Palen,Gerhard Zielhuis,Cees van Herwaarden	14
10	Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: The COPE Study 2002 ·American Journal of Respiratory and Critical Care Medicine ·Paul van der Valk,Evelyn M. Monninkhof,Job van der Palen,Gerhard Zielhuis,Cees van Herwaarden	217
11	The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design 2001 ·European Respiratory Journal ·Marc Decramer,P. N. Richard Dekhuijzen,Thierry Troosters,Cees van Herwaarden,Maureen Rutten‐van Mölken,(unknown),Dario Olivieri,(unknown),Alfredo Ardia	42
12	The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis 2001 ·Infection ·Reinout van Crevel,Wiel C.M. de Lange,(unknown),Dick van Soolingen,J. A. A. Hoogkamp‐Korstanje,(unknown),Bart Jan Kullberg,Cees van Herwaarden,(unknown)	21
13	Underpresentation of shortness of breath in the general population: Results of the DIMCA programme 1999 ·Primary Care Respiratory Journal ·G. van den Boom,(unknown),Ad A. Kaptein,Ilse Mesters,Cees van Herwaarden,Reinier Akkermans,Chris van Weel,Onno C. P. van Schayck	5
14	Eleven peak flow meters: a clinical evaluation 1998 ·European Respiratory Journal ·(unknown),(unknown),(unknown),Cees van Herwaarden	15
15	Recommendations based on guidelines on the management of mild to moderately severe chronic obstructive pulmonary disease: some practical applications in primary care 1998 ·Primary Care Respiratory Journal ·Onno C. P. van Schayck,Chris van Weel,Cees van Herwaarden,Peter J. Barnes,K. S. Jones,J. André Knottnerus,Emiel F.�M. Wouters,(unknown),(unknown)	1
16	Bronchial responsiveness to histamine and methacholine measured with forced expirations and with the forced oscillation technique 1995 ·Respiratory Medicine ·Els J.M. Weersink,(unknown),Cees van Herwaarden,H. Folgering	21
17	Exercise Limitations in Patients with Pulmonary Diseases 1994 ·International Journal of Sports Medicine ·H. Folgering,Cees van Herwaarden	24
18	Education and cost/benefit ratios in pulmonary patients. 1994 ·PubMed ·H. Folgering,(unknown),Cees van Herwaarden	5
19	Symptoms, physical performance and psychosocial parameters before and after pulmonary rehabilitation 1992 ·International Journal of Rehabilitation Research ·(unknown),Jeroen Hendriks,R. A. Binkhorst,Cees van Herwaarden	4
20	Refractoriness for ultrasonically nebulized distilled water and histamine after histamine challenge 1991 ·Journal of Applied Physiology ·(unknown),JW Lammers,Jan Festen,Cees van Herwaarden	7

About Cees van Herwaarden

Cees van Herwaarden is a scholar working on Issues, ethics and legal aspects, Pulmonary and Respiratory Medicine and Emergency Medical Services, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Respiratory Support and Mechanisms (10 papers) and Asthma and respiratory diseases (9 papers). The work is most often cited by research in Issues, ethics and legal aspects (79 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Physiology (558 citations). Cees van Herwaarden has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Job van der Palen, Gerhard Zielhuis, Paul van der Valk, Evelyn M. Monninkhof, Marc Decramer, Maureen Rutten‐van Mölken, Dario Olivieri, Wilfried De Backer, Mario Del Donno and Thierry Troosters. Their work appears in journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact